Giggles N’ Hugs Signs Agreement with New York-Based

New Post Public Reply Private Reply Replies (1) Message Board
Thoth Thoth #1814
298
Giggles N’ Hugs Signs Agreement with New York-Based Chardan Capital Markets

Giggles N’ Hugs, Inc. (OTCQB: GIGL), owner and operator of family-friendly restaurants that bring together high-end, organic food with active, cutting-edge play and entertainment for children, has engaged Chardan Capital Markets, LLC (“Chardan”) a boutique investment bank headquartered in New York.

Under the agreement, Chardan will introduce Giggles N’ Hugs to potential investors and business partners, advise and assist management in preparing for presentations to financial sources, as well as perform a wide variety of financial advisory services.

“We are extremely pleased to have reached this agreement with Chardan Capital Markets,” said Joey Parsi, Founder and CEO of Giggles N’ Hugs. “As we continue to grow and expand our reach in markets throughout the country and the world, we look forward to working with Chardan to assist in taking our company to the next level through their capital markets and financial advisory expertise. In addition, markets permitting, we plan to take the necessary steps to position Giggles N’ Hugs for an up-listing to a national exchange in 2016.” <--- Men, I believe this was delayed but will happen sooner than most think. Joey has come through on EVERYTHING, no reason to believe he isn't still working on this

Chardan specializes in providing the entire gamut of investment banking, trading and equity research, with a particular emphasis on micro-cap emerging growth companies . With over $13.0 billion raised through more than 250 transactions, Chardan has developed a successful record of completing a wide variety of deals. In the process, Chardan has become a leader on capital solutions for emerging growth companies.

Who is Chardan you ask?

Chardan is committed to providing clients with a full range of services which include capital raising, merger and acquisition advisory, equity research, institutional trading, and market making. We are driven by the desire to deliver excellence to our clients and possess a genuine passion for what we do. We pride ourselves on our balanced approach to financial advisory to both corporate and institutional clients.

Chardan is known across the industry for our innovative thinking, enthusiasm, and dedication. We’ve developed a culture of integrity and transparency that, even as we grow rapidly, continues to be guided by a strong conscience and solid ethical values.

Our experienced professionals pursue a deep understanding of our clients’ needs and leverage their global relationships to provide exceptional value and insight. With a truly established record of success we have helped raise over $15 billion for our corporate clients through hundreds of capital market transactions. This has earned us a stellar reputation as the firm companies depend on to close particularly complex and challenging deals.

Our clients know that every investment opportunity we recommend is backed by years of market experience, that the research we deliver is detailed, objective, and tailored to their needs, and that every trade they place through us will be executed with precision and discretion.

Clients look to Chardan for honest advice and high quality, creative investment ideas. They continue to work with us because we consistently deliver on that promise.

http://chardan.com/who-we-are/

Giggles And Hugs Inc (GIGL) Stock Research Links

GIGL Board Company Profile Buy Rating Time & Sales News Filings Financials
mA2IsJPWGJ-how-do-you-feel-about-gigl-bulls.gif
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 13

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 24

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 19

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Inbank Reports Impressive Growth in Financial Performance

Updated Category News Views 237

Inbank's Stellar Financial Performance in Recent Quarters Inbank has achieved significant milestones in its Q2 2025 financial results, showcasing dynamic growth and resilience in a fluctuating market. The bank reported a remarkable originated volume of 196 million euros, marking a 15% increase from the previous year. Although consolidated net profit saw a slight decline...

Continue Reading
Navient Elects Edward Bramson as Chair After Shareholder Meeting

Updated Category News Views 164

Navient's Annual Meeting Marks a New Chapter HERNDON, Va. - Recently, Navient (Nasdaq: NAVI) convened its Annual Meeting of Shareholders, setting the stage for significant leadership changes within the company. This year, shareholders engaged actively, voting to approve three pivotal proposals outlined by the board of directors. This included the election of seven new...

Continue Reading
Annexon Secures $75 Million in Public Stock Offering

Updated Category News Views 184

Overview of Annexon's Recent Public Offering Annexon, Inc. (NASDAQ: ANNX), a pioneering biopharmaceutical firm, recently announced the successful pricing of its public offering aimed at raising $75 million. This exciting event took place as the company continues to push forward with its mission to address neuroinflammation and related diseases, facilitating groundbreaking...

Continue Reading
Werner Enterprises Set for Key Investment Conferences This Year

Updated Category News Views 310

Werner Enterprises is Poised for Investment Conference Engagements Werner Enterprises, Inc. (Nasdaq: WERN), a well-known name in transportation and logistics, is preparing to participate in several significant investment conferences. These events present a fantastic opportunity for the company to share insights about its growth strategies and market position. Upcoming...

Continue Reading
Cunard Achieves Unprecedented Booking Milestones in 2024

Updated Category News Views 156

Record-Breaking Booking Success for Cunard Cunard has recently announced remarkable booking figures for the year 2024, driven by a stellar year and the eagerly awaited introduction of its ship, Queen Anne. This significant increase has resulted in an astonishing 73,000 more guest reservations from January to October compared to the same timeframe in the previous year,...

Continue Reading